LifeBio Memory: Development of a Reminiscence Therapy Online Platform With Machine Learning to Increase Engagement
- Sponsor
- George Mason University
- Study ID
- NCT07685067
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Mild Cognitive Impairment
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- LifeBio Memory (LBM) digital reminiscence intervention — OTHERLifeBioMEMORY (LBM) is a multilingual digital reminiscence therapy platform that guides older adults through life story sharing using culturally relevant prompts, photos, and voice recording in Spanish, Korean, or English. The app includes "My Story" and "Fun Things to Do" features to support reminiscence and engagement while capturing personal narratives. Using machine learning, LBM generates personalized Life Story Books and summaries in the preferred language of the older adult and informal caregiver, with electronic and printed copies available. The intervention is designed to promote social engagement, strengthen caregiver relationships, and support person-centered care.
Study Details
LifeBioMEMORY (LBM) is a reminiscence therapy (RT) mobile application that captures older adults' life stories in their own voices to promote social engagement and psychosocial well-being. This study will develop and evaluate an enhanced multilingual LBM app for community-dwelling, diverse older adults with mild cognitive impairment (MCI) or at risk of MCI and their informal caregivers, including Hispanic/Latino, Asian American (as one of subgroups, Korean), Black or African American, and non-Hispanic White populations. The app provides culturally tailored life story prompts with audio and visual cues to encourage reminiscence and storytelling. The intervention aims to improve quality of life, reduce depressive symptoms and loneliness, and strengthen caregiver-care recipient relationships, with the potential to provide an accessible, non-pharmacological approach to supporting cognitive and emotional well-being.
Key Dates
- First listed
- Jul 6, 2026
- Start date
- Aug 1, 2026
- Status verified
- Jun 2026
- Primary completion
- May 31, 2028
- Completion
- May 31, 2028
Study Design
- Enrollment
- 168 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: LifeBio Memory (LBM) digital reminiscence interventionParticipants will access the LifeBio Memory (LBM) digital reminiscence platform using a mobile phone or tablet. Informal caregivers will complete a brief training. During Weeks 1-2, dyads will complete at least two weekly sessions recording the older adult's life stories using structured prompts. During Weeks 3-5, dyads will complete one weekly reminiscence and social engagement session. In Week 6, participants will receive personalized LifeBio story materials, including a Life Story Book, Snapshot, and story summary.
- Active Comparator: Waitlist Control (Delayed LBM digital reminiscence intervention)Participants will receive general education on brain health and information about available local social services during the control period. After the control period, participants will participate in the LifeBio Memory (LBM) App intervention.
Primary Outcome Measure
Primary Outcome [ Time Frame: Assessments will be conducted at baseline, 6 weeks, and 10 weeks. ]
Central Contacts
- Kyeung Mi Oh, PhD703 993 4550
Related Studies
- Wisconsin Brain Donor ProgramEnrolling By Invitation · University of Wisconsin, Madison · Madison, Wisconsin
- DaTSCAN Imaging in Aging and Neurodegenerative DiseasePHASE4 · Enrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Quality Improvement and Practice Based Research in Neurology Using the EMRPHASE4 · Enrolling By Invitation · Endeavor Health · Evanston, Illinois
- Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's DiseaseEnrolling By Invitation · Wake Forest University Health Sciences · Winston-Salem, North Carolina